Modulation of biomarkers of inflammation and bone turnover and associations with bone mineral density in ankylosing spondylitis (AS) patients treated with infliximab

被引：0
|
作者：
Visvanathan, S.
Deodhar, A.
Braun, J.
Van der Heijde, D.
Yan, S.
Gathany, T.
Geusens, P.
Williamson, P.
Wagner, C.
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR 97201 USA
[2] Rheumazentrum Ruhrgebiet, Herne, Germany
[3] Univ Hosp Maastricht, Maastricht, Netherlands
[4] Centocor Inc, Res & Dev, Malvern, PA 19355 USA
[5] Univ Hasselt, Diepenbeek, Belgium
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2006年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：547 / 547
页数：1
相关论文
共 50 条
  • [1] Effects of infliximab on markers of inflammation and bone turnover and associations with bone mineral density in patients with ankylosing spondylitis
    Visvanathan, S.
    van der Heijde, D.
    Deodhar, A.
    Wagner, C.
    Baker, D. G.
    Han, J.
    Braun, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (02) : 175 - 182
  • [2] EVALUATION OF BONE MINERAL DENSITY AND BONE TURNOVER MARKERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Sahin, N.
    Ozcan, E.
    Ozkaya, M.
    Erkan, S.
    Omer, B.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S244 - S244
  • [3] EVALUATION OF BONE MINERAL DENSITY AND BONE TURNOVER MARKERS IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Sahin, N.
    Ozcan, E.
    Ozkaya, M.
    Erkan, S.
    Omer, B.
    OSTEOPOROSIS INTERNATIONAL, 2020, 31 (SUPPL 1) : S206 - S207
  • [4] Bone mineral density in patients with ankylosing spondylitis
    Altindag, Oezlem
    Karakoc, Mehmet
    Soran, Neslihan
    Tabur, Hasan
    Demirkol, Ahmet
    ROMATIZMA-RHEUMATISM, 2008, 23 (02): : 42 - 45
  • [5] EFFECTS OF ANTI-TNFS ON BONE MINERAL DENSITY AND BONE TURNOVER IN PATIENTS WITH ANKYLOSING SPONDYLITIS
    Ancuta, Codrina
    Ancuta, Eugen
    Macovei, Luana
    Miu, Smaranda
    Iordache, Cristina
    Chirieac, Rodica
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 321 - 321
  • [6] Comment on bone mineral density and bone turnover markers in a group of male ankylosing spondylitis patients
    Korkosz, M
    Gluszko, P
    Marcinek, P
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2002, 8 (06) : 359 - 360
  • [7] OSTEOPOROSIS IN ANKYLOSING SPONDYLITIS: FOCUS ON BONE MINERAL DENSITY AND BONE METABOLISM BIOMARKERS
    Ancuta, C.
    Ancuta, E.
    Iordache, C.
    Belibou, C.
    Chirieac, R.
    OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 82 - 83
  • [8] The effect of infliximab on inflammation and bone formation biomarkers and associations with clinical response in ankylosing spondylitis and psoriatic arthritis
    Visvanathan, S.
    Marano, C.
    Braun, J.
    Kavanaugh, A.
    Gathany, T.
    Xu, S.
    Han, J.
    Baker, D.
    Wagner, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 413 - 413
  • [9] The effect of infliximab on inflammation & bone formation biomarkers: Associations with clinical response in ankylosing spondylitis & psoriatic arthritis
    Visvanathan, S.
    Marano, C.
    Braun, J.
    Kavanaugh, A.
    Gathany, T.
    Xu, S.
    Han, J.
    Baker, D.
    Wagner, C.
    RHEUMATOLOGY, 2008, 47 : II80 - II80
  • [10] Bone mineral density, calcaneal ultrasound, and bone turnover markers in women with ankylosing spondylitis
    Speden, DJ
    Calin, AI
    Ring, FJ
    Bhalla, AK
    JOURNAL OF RHEUMATOLOGY, 2002, 29 (03) : 516 - 521
12345